Xenon, Amsterdam deal

Xenon Genetics (Vancouver, B.C.) granted Amsterdam Molecular Therapeutics (Amsterdam, the Netherlands) access to its lipoprotein lipase (LPL) technology. The companies will conduct preclinical LPL gen...